Nippon India Pharma Fund-Growth Plan-Growth Option

arrow-up
NAV
₹ 499.1941 ₹ 4.57 (0.91 %)
as on 19-11-2024
Asset Size (AUM)
8,688.65 Cr
Launch Date
Jun 01, 2004
Investment Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
Minimum Investment 5000.0
Minimum Top-up 1000.0
Investment Returns Since Launch in Jun 01, 2004
arrow-up

21.05

%
3 M
6 M
1 Y
3 Y
10 Y
Inception
Sharp Ratio
0.88 %
Expense Ratio
1.81%
Volatility
14.36 %
Fund House
Nippon India Mutual Fund
Fund Manager
Sailesh Raj Bhan
Key Features
Scheme description
This fund has higher ups and downs compared to other equity funds but can give much higher returns. Investment in this fund can be made for a horizon of at least 5-7 years or more
Minimum Purchase Application Amount
Rs. 5000.0 (plus in multiples of Rs. 1000.0)

Entry Load
Not applicable
Exit Load
levied on the Units redeemed will be the rate prevailing at the time of the allotment of the Units. For Special products registrations, load for each transaction is based on the load structure applicable as on the registration date.
Indicative Investment Horizon
5 Years and above
Asset Allocation
Fund's historical return comparison with other asset classes
Fund Performance
Fund's historical return comparison with other asset classes
Performance

Scheme Performance (%)

Data as on - 19-11-2024

Yearly Performance (%)

Investment Returns Calculator
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Peer Comparison
Scheme Name Inception Date 1 Year Return % 2 Year Return % 3 Year Return % 5 Year Return % 10 Year Return %
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 35.35 32.19 18.23 27.41 15.01
HDFC Pharma and Healthcare Fund - Growth Option 05-10-2023 50.48 0.0 0.0 0.0 0.0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 25-07-2018 47.44 39.05 23.15 30.05 0.0
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 46.41 35.26 21.24 30.75 0.0
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 44.04 35.5 19.66 27.48 12.74
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 08-11-2021 43.69 31.35 18.22 0.0 0.0
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 43.18 35.16 22.9 28.63 13.41
LIC MF Healthcare Fund-Regular Plan-Growth 22-02-2019 42.99 30.12 15.82 22.77 0.0
Quant Healthcare Fund - Growth Option - Regular Plan 11-07-2023 42.03 0.0 0.0 0.0 0.0
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 38.91 32.26 19.21 26.43 0.0
Portfolio Analysis
Portfolio as on
Sector Allocation
Sector Allocation (%)
Portfolio Holdings
Company Allocation (%)
Sector Allocation
Portfolio Holdings